Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavlos Msaouel

Showing results (41-50 of 246) with videos related to

Pageof 25
Sort By:
JAMA Oncology|October 30, 2025
Rethinking End Points in Modern Oncology Trials-Beyond the P Value-ReplyAlexander D Sherry, Pavlos Msaouel, Ethan B Ludmir
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2018
A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary CarcinomaPavlos Msaouel, Nizar M Tannir, Cheryl Lyn Walker
Expert Opinion on Emerging Drugs|July 3, 2007
Luteinising hormone-releasing hormone antagonists in prostate cancer therapyPavlos Msaouel, Evanthia Diamanti, Marinela Tzanela, et al.
Lancet (London, England)|February 1, 2025
Sunitinib for the treatment of phaeochromocytomas and paragangliomasAlexander D Sherry, Ethan B Ludmir, Pavlos Msaouel
European Urology|November 7, 2016
Linking Gene Mutations to Clinical Outcomes and Response to Therapy in Clear-cell Renal Cell Carcinoma: Ready for Prime Time?Pavlos Msaouel, Gabriel G Malouf, Nizar M Tannir
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2025
Random Assignment, But Without Comparison: A Missed OpportunityAlexander D Sherry, Ethan B Ludmir, Pavlos Msaouel
Expert Opinion on Investigational Drugs|September 13, 2013
Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancerPavlos Msaouel, Gayathri Nandikolla, Spyros G Pneumaticos, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|January 30, 2023
Utility-based Bayesian personalized treatment selection for advanced breast cancerJuhee Lee, Peter F Thall, Bora Lim, et al.
Clinical Genitourinary Cancer|December 28, 2020
Systemic Therapies for the Management of Non-Clear Cell Renal Cell Carcinoma: What Works, What Doesn't, and What the Future HoldsPanagiotis Zoumpourlis, Giannicola Genovese, Nizar M Tannir, et al.
Expert Opinion on Biological Therapy|January 8, 2013
Oncolytic measles virus strains as novel anticancer agentsPavlos Msaouel, Mateusz Opyrchal, Evidio Domingo Musibay, et al.
Pageof 25

Showing results (41-50 of 246) with videos related to

Sort By:
Pageof 25
JAMA Oncology|October 30, 2025
Rethinking End Points in Modern Oncology Trials-Beyond the P Value-ReplyAlexander D Sherry, Pavlos Msaouel, Ethan B Ludmir
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2018
A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary CarcinomaPavlos Msaouel, Nizar M Tannir, Cheryl Lyn Walker
Expert Opinion on Emerging Drugs|July 3, 2007
Luteinising hormone-releasing hormone antagonists in prostate cancer therapyPavlos Msaouel, Evanthia Diamanti, Marinela Tzanela, et al.
Lancet (London, England)|February 1, 2025
Sunitinib for the treatment of phaeochromocytomas and paragangliomasAlexander D Sherry, Ethan B Ludmir, Pavlos Msaouel
European Urology|November 7, 2016
Linking Gene Mutations to Clinical Outcomes and Response to Therapy in Clear-cell Renal Cell Carcinoma: Ready for Prime Time?Pavlos Msaouel, Gabriel G Malouf, Nizar M Tannir
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2025
Random Assignment, But Without Comparison: A Missed OpportunityAlexander D Sherry, Ethan B Ludmir, Pavlos Msaouel
Expert Opinion on Investigational Drugs|September 13, 2013
Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancerPavlos Msaouel, Gayathri Nandikolla, Spyros G Pneumaticos, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|January 30, 2023
Utility-based Bayesian personalized treatment selection for advanced breast cancerJuhee Lee, Peter F Thall, Bora Lim, et al.
Clinical Genitourinary Cancer|December 28, 2020
Systemic Therapies for the Management of Non-Clear Cell Renal Cell Carcinoma: What Works, What Doesn't, and What the Future HoldsPanagiotis Zoumpourlis, Giannicola Genovese, Nizar M Tannir, et al.
Expert Opinion on Biological Therapy|January 8, 2013
Oncolytic measles virus strains as novel anticancer agentsPavlos Msaouel, Mateusz Opyrchal, Evidio Domingo Musibay, et al.
Pageof 25